Facebook Linkedin RSS Twitter Youtube
Home 2018

Qiagen

FDA Extends Approval for Qiagen NSCLC Test as CDx to Boehringer Ingelheim’s Gilotrif
Cancer

FDA Extends Approval for Qiagen NSCLC Test as CDx to Boehringer Ingelheim’s Gilotrif

BMS, Qiagen to Develop Gene Expression Profiles for Immuno-Oncology Therapies
Cancer

BMS, Qiagen to Develop Gene Expression Profiles for Immuno-Oncology Therapies

Genomics England Chooses Qiagen’s Human Gene Mutation Database
Industry News

Genomics England Chooses Qiagen’s Human Gene Mutation Database

Tokai Ends Phase III Trial of Lead Candidate Galeterone
Cancer

Tokai Ends Phase III Trial of Lead Candidate Galeterone

Liquid Biopsies Are Finding the Genetic Material in the Cellular Haystack
Insights

Liquid Biopsies Are Finding the Genetic Material in the Cellular Haystack

Hitachi High-Tech, Qiagen Enter Molecular Testing Collaboration
News

Hitachi High-Tech, Qiagen Enter Molecular Testing Collaboration

NGS: Target-Enrichment Strategies Enable Precision Medicine
Multimedia

NGS: Target-Enrichment Strategies Enable Precision Medicine

Cell Analysis Flourishes Scientifically, Prospers Commercially
Insights

Cell Analysis Flourishes Scientifically, Prospers Commercially

Qiagen Acquires Novel Circulating Tumor Cell Technology for Liquid Biopsies
Cancer

Qiagen Acquires Novel Circulating Tumor Cell Technology for Liquid Biopsies

What’s Next for Next-Gen Sequencing?
Insights

What’s Next for Next-Gen Sequencing?

1234...12Page 3 of 12
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.